HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry.
Saved in:
| Title: | HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry. |
|---|---|
| Source: | Retrovirology. 2011, Vol. 8 Issue 1, p89-95. 7p. 4 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
